IL37 and psoriasis: The aim of the study was to investigate the potential role of naringin/sericin combination for the treatment of psoriasis through inhibition of the expression of mRNA and the production of cytokines involved in the inflammatory process (TNF-α, IL-6, IL-23, and IL-12p40) [11] to use in complementary medicine.